OraSure Technologies Inc (OSUR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:OraSure Technologies Inc (OSUR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010884
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and antigens for influenza type A and type B. OraSure also sells immunoassay tests and reagents for insurance risk assessment, substance-abuse testing and forensic toxicology applications; and products for the cryosurgical removal of warts and several other benign skin lesions. The company distributes its products to various hospitals, clinics, community-based organizations and other public health organizations, distributors, clinical laboratories, and commercial and industrial entities. The company sells its products through distributors in the Americas, Europe and Asia-Pacific. OraSure is headquartered in Bethlehem, Pennsylvania, the US.

OraSure Technologies Inc (OSUR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
OraSure Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
OraSure Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
OraSure Technologies Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
OraSure Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
OraSure Technologies Inc, Medical Equipment, Deal Details 10
Partnerships 10
OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 10
DNA Genotek Enters Into Distribution Agreement With Abyntek Biopharma 11
Equity Offering 12
Orasure Technologies Files Shelf Registration Statement For Public Offering Of Securities For US$200 Million 12
OraSure Technologies Completes Public Offering Of Common Stock For US$75 Million 13
Acquisition 14
OraSure Technologies Completes Acquisition Of DNA Genotek 14
OraSure Technologies Inc – Key Competitors 16
OraSure Technologies Inc – Key Employees 17
OraSure Technologies Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 01, 2017: OraSure Announces 2017 Third Quarter Financial Results 19
Aug 02, 2017: OraSure Announces 2017 Second Quarter Financial Results 21
May 03, 2017: OraSure Announces 2017 First Quarter Financial Results 23
Feb 08, 2017: OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results 25
Nov 02, 2016: OraSure Announces 2016 Third Quarter Financial Results 27
Aug 03, 2016: OraSure Announces 2016 Second Quarter Financial Results 29
May 04, 2016: OraSure Announces 2016 First Quarter Financial Results 31
Feb 03, 2016: OraSure Announces Record Revenues for Full-Year and Fourth Quarter 2015 32
Corporate Communications 34
Jun 22, 2017: OraSure Technologies Appoints Mara G. Aspinall to Board of Directors 34
Feb 24, 2017: OraSure Technologies Announces Director Retirement 35
Nov 15, 2016: OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors 36
Apr 15, 2016: OraSure Technologies Appoints New Chief Science Officer 37
Mar 23, 2016: OraSure Technologies Appoints Eamonn P. Hobbs to its Board of Directors 38
Legal and Regulatory 39
Feb 06, 2017: OraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA 39
Other Significant Developments 40
Nov 29, 2016: OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program 40
Aug 23, 2016: HHS awards $7 Million to OraSure to Speed Development of Zika Diagnostic Test 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
OraSure Technologies Inc, Medical Equipment, Key Facts, 2016 2
OraSure Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
OraSure Technologies Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
OraSure Technologies Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
OraSure Technologies Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
OraSure Technologies Inc, Deals By Market, 2011 to YTD 2017 8
OraSure Technologies Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 10
DNA Genotek Enters Into Distribution Agreement With Abyntek Biopharma 11
Orasure Technologies Files Shelf Registration Statement For Public Offering Of Securities For US$200 Million 12
OraSure Technologies Completes Public Offering Of Common Stock For US$75 Million 13
OraSure Technologies Completes Acquisition Of DNA Genotek 14
OraSure Technologies Inc, Key Competitors 16
OraSure Technologies Inc, Key Employees 17
OraSure Technologies Inc, Other Locations 18
OraSure Technologies Inc, Subsidiaries 18

★海外企業調査レポート[OraSure Technologies Inc (OSUR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TGS-NOPEC Geophysical Company ASA (TGS):石油・ガス:M&Aディール及び事業提携情報
    Summary TGS-NOPEC Geophysical Company ASA (TGS) is a provider of exploration services. It offers multi-client geosciences data to oil and gas exploration and production companies. The company offers a range of global geophysical and geological data libraries including multi-client seismic data, magn …
  • Foamix Pharmaceuticals Ltd (FOMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Foamix Pharmaceuticals Ltd (Foamix), formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company’s product candidates include FMX101, a minocycline foam which is intended for the treatment of mod …
  • Svenska Cellulosa AB:戦略・SWOT・企業財務分析
    Svenska Cellulosa AB - Strategy, SWOT and Corporate Finance Report Summary Svenska Cellulosa AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vital Therapies Inc (VTL)-医療機器分野:企業M&A・提携分析
    Summary Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute l …
  • HeartWare International Inc:企業の戦略的SWOT分析
    HeartWare International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Cosmo Oil Co Ltd:企業の戦略的SWOT分析
    Cosmo Oil Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • BrainStorm Cell Therapeutics Inc (BCLI):企業の財務・戦略的SWOT分析
    Summary BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy pl …
  • Dare Bioscience Inc (DARE):医療機器:M&Aディール及び事業提携情報
    Summary Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, re …
  • Saponia D.D.:企業の戦略・SWOT・財務分析
    Saponia D.D. - Strategy, SWOT and Corporate Finance Report Summary Saponia D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Yum China Holdings Inc (YUMC):企業の財務・戦略的SWOT分析
    Yum China Holdings Inc (YUMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Houghton Mifflin Harcourt Company:企業のM&A・事業提携・投資動向
    Houghton Mifflin Harcourt Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Houghton Mifflin Harcourt Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Sykes Enterprises Inc (SYKE):企業の財務・戦略的SWOT分析
    Sykes Enterprises Inc (SYKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sv. Sv. Konstantin I Elena Holding Ad
    Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report Summary Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Tetragenetics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tetragenetics Inc (Tetragenetics) is a biotechnology company that discovers and develops therapeutics for autoimmune disease and pain. The company develops antibodies for autoimmune disorders, pains and other. Its autoimmune disorders include Type 1 Diabetes Mellitus, rheumatoid arthritis, m …
  • Koppers Holdings Inc (KOP):企業の財務・戦略的SWOT分析
    Koppers Holdings Inc (KOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Strabag SE:企業のM&A・事業提携・投資動向
    Strabag SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Strabag SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Coloplast AS (COLO B):医療機器:M&Aディール及び事業提携情報
    Summary Coloplast A/S (Coloplast) is a medical device company that offers products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advance …
  • PT Rekayasa Industri:企業の戦略的SWOT分析
    PT Rekayasa Industri - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Embotelladora Andina SA (ANDINA-B):企業の財務・戦略的SWOT分析
    Embotelladora Andina SA (ANDINA-B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cobra Electronics Corporation:企業の戦略的SWOT分析
    Cobra Electronics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆